陈椿, 曾康辉. Ⅰ B~ⅢA期非小细胞肺癌患者手术切除 + 辅助化疗后阿特珠单抗治疗的临床研究评价[J]. 循证医学, 2022, 22(1): 30-33. DOI: 10.12019/j.issn.1671-5144.2022.01.007
    引用本文: 陈椿, 曾康辉. Ⅰ B~ⅢA期非小细胞肺癌患者手术切除 + 辅助化疗后阿特珠单抗治疗的临床研究评价[J]. 循证医学, 2022, 22(1): 30-33. DOI: 10.12019/j.issn.1671-5144.2022.01.007
    CHEN Chun, ZENG Kang-hui. Review of Adjuvant Atezolizumab After Adjuvant Chemotherapy in Resected StageⅠB~ⅢA Non-Small-Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2022, 22(1): 30-33. DOI: 10.12019/j.issn.1671-5144.2022.01.007
    Citation: CHEN Chun, ZENG Kang-hui. Review of Adjuvant Atezolizumab After Adjuvant Chemotherapy in Resected StageⅠB~ⅢA Non-Small-Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2022, 22(1): 30-33. DOI: 10.12019/j.issn.1671-5144.2022.01.007

    Ⅰ B~ⅢA期非小细胞肺癌患者手术切除 + 辅助化疗后阿特珠单抗治疗的临床研究评价

    Review of Adjuvant Atezolizumab After Adjuvant Chemotherapy in Resected StageⅠB~ⅢA Non-Small-Cell Lung Cancer

    /

    返回文章
    返回